Impact of low-density lipoprotein cholesterol-lowering therapy on intermediate stenosis in non-culprit vessels of acute coronary syndrome

Kakehi et al. (Fri,) studied this question.

www.synapsesocial.com/papers/69402df12d562116f290411e — DOI: https://doi.org/10.1186/s12872-025-05395-z

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy· 2013 · 1,250 citations
2. Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis· 2007 · 729 citations
3. Endothelial Dysfunction· 2003 · 2,184 citations
4. Revascularization Deferral of Nonculprit Stenoses on the Basis of Fractional Flow Reserve· 2020 · 50 citations
5. Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography· 2016 · 586 citations